Akura Medical begins patient enrollment in QUADRA-PE study of Katana Thrombectomy System to treat acute pulmonary embolism: Los Gatos, California Thursday, February 6, 2025, 18:00 ...
Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/105.BC69AuN1.js ...
Akura Medical, Inc., a privately held portfolio company of Shifamed LLC that is developing treatments for venous thromboembolis ...
Akura Medical, a Shifamed portfolio company focused on reshaping the landscape of venous thromboembolism (VTE) care, announced today the first patient enrollment in the QUADRA-PE study (NCT06672510) ...
Dr. Silver moderates a panel of experts who discuss their experiences with the Neuroguard IEP® System, insights into the data, device design characteristics, and impact on the field. By Mitchell J.